Fundraising Fox
Vertero Therapeutics, Inc.
Founded 2016 · 12 employees on LinkedIn · 5 known investors
Find your way into Vertero Therapeutics, Inc.
Sign up to see every warm intro you have to Vertero Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vertero Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
Founders & leadership
Vertero Therapeutics, Inc. was founded in 2016 by Sarkis Mazmanian, PhD.
SM
Sarkis Mazmanian, PhDCo-founder and Board Member
Investors · 5
AIFlisted by AIFNew York
How we know: AIF's portfolio page · Not right? Tell us
OneVentureslisted by OneVenturesSydney · $3.3M – $13.2M
How we know: OneVentures's portfolio page · Not right? Tell us
Frequently asked questions
- What does Vertero Therapeutics, Inc. do?
- Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
- Who founded Vertero Therapeutics, Inc.?
- Vertero Therapeutics, Inc. was founded by Sarkis Mazmanian, PhD in 2016.
- Who are Vertero Therapeutics, Inc.'s investors?
- Vertero Therapeutics, Inc.'s investors include AIF, OneVentures, Seventure Partners, Taiho Ventures, LLC, UTokyo Innovation Platform Co. Ltd..